MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on March 28, 2006; DOI: 10.1124/mol.105.022103


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.105.022103v1
70/1/241    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, H. Y.
Right arrow Articles by Bae, Y.-S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, H. Y.
Right arrow Articles by Bae, Y.-S.


Received for publication December 28, 2005.
Revised March 21, 2006.
Accepted for publication March 28, 2006.

Serum amyloid A induces contrary immune responses via formyl peptide receptor like-1 in human monocytes

Ha Young Lee 1, Mi-Kyoung Kim 1, Kyoung Sun Park 1, Eun Ha Shin 1, Seong Ho Jo 1, Sang Doo Kim 1, Eun Jin Jo 1, Youl-Nam Lee 1, Chuhee Lee 2, Suk-Hwan Baek 2, Yoe-Sik Bae 1*

1 Dong-A University College of Medicine 2 Yeungnam University College of Medicine

* Address correspondence to: E-mail: yoesik{at}donga.ac.kr

Abstract

Although the level of serum amyloid A has been reported to be up-regulated during inflammatory response, the role of serum amyloid A on the regulation of inflammation and immune response has not been elucidated. We found that serum amyloid A stimulated the production of tumor necrosis factor-{alpha} (TNF-{alpha}) and IL-10, which are, proinflammatory and anti-inflammatory cytokines, respectively in human monocytes. Low concentrations of serum amyloid A stimulated TNF-{alpha} production with maximal activity at 6 hr after stimulation, whereas high concentrations of serum amyloid A stimulated IL-10 production with maximal activity at 12 hr. The activations of the two cytokines by serum amyloid A occurred at both the transcription and translational levels. Signaling events induced by serum amyloid A included the activation of two mitogen activated protein kinase (extracellular signal-regulated kinase and p38 kinase), which were found to be required for TNF-{alpha} and IL-10 production, respectively. The stimulation of formyl peptide receptor like 1-expressing RBL-2H3 cells, but not of vector-expressing RBL-2H3 cells with serum amyloid A, induced mitogen activated protein kinases activation and the accumulation of the RNAs of these two cytokines. Taken together, our findings suggest that serum amyloid A modulates contrary immune responses via formyl peptide receptor like 1, by inducing TNF-{alpha} or IL-10, and demonstrate that extracellular signal-regulated kinase and p38 kinase play counteracting roles in this process.


Key words: Interleukins, Gi family, Calcium (G Protein Coupled Signals), MAP Kinase, P38 MAP Kinase


This article has been cited by other articles:


Home page
J. Immunol.Home page
H. Y. Lee, S. D. Kim, J. W. Shim, S. Y. Lee, H. Lee, K.-H. Cho, J. Yun, and Y.-S. Bae
Serum Amyloid A Induces CCL2 Production via Formyl Peptide Receptor-Like 1-Mediated Signaling in Human Monocytes
J. Immunol., September 15, 2008; 181(6): 4332 - 4339.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
F. B. Hickey, C. F. Brereton, and K. H. G. Mills
Adenylate cycalse toxin of Bordetella pertussis inhibits TLR-induced IRF-1 and IRF-8 activation and IL-12 production and enhances IL-10 through MAPK activation in dendritic cells
J. Leukoc. Biol., July 1, 2008; 84(1): 234 - 243.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. Sandri, D. Rodriguez, E. Gomes, H. P. Monteiro, M. Russo, and A. Campa
Is serum amyloid A an endogenous TLR4 agonist?
J. Leukoc. Biol., May 1, 2008; 83(5): 1174 - 1180.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics